| | Business Summary | | Sepragen
Corporation
is
a
provider
of
high
throughput
equipment,
systems
and
materials
for
the
scale-up
and
manufacture
of
biotech
drugs
and
nutraceutical.
The
Company
develops
and
markets
technology,
equipment
and
resins
to
extract
and
purify
biopharmaceuticals,
nutritional
and
beverage
products.
Sepragen's
products
are
based
on
RFC
technology,
which
the
Company
believes
enables
the
purification
of
greater
quantities
of
product
more
efficiently
than
with
conventional
chromatography
along
with
providing
a
measurable
economic
advantage. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Sepragen
Corp.
develops,
assembles
and
markets
liquid
chromatography
equipment,
resins
and
processes
systems
for
the
separation
and
purification
of
biopharmaceuticals
and
food
and
beverage
products.
For
the
three
months
ended
3/31/01,
net
sales
rose
27%
to
$354
thousand.
Net
loss
fell
6%
to
$279
thousand.
Revenues
reflect
increased
sales
of
QuantaSep
product
line.
Lower
losses
were
partially
offset
by
the
Company's
relocation
expenses. | | More
from
Market Guide: Significant
Developments |
| | Officers | | | FY2000 Pay | |
| Vinit Saxena, 45
Chairman,
Pres, CEO | $134K | Henry Edmunds, Ph.D., 58
Acting
CFO, Director | -- | Armin Ramel, Ph.D., 75
Sec. | -- | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/s/spgna.ob.gif)